Characteristics | Â | P value |
---|---|---|
Age in years, mean ± SD | 61.8 ± 11.8 | < 0.001a |
Female gender, number (percentage) | 251 (71.7) | NSb |
White-British race, number (percentage) | 336 (96) | NSb |
RF-positive, number (percentage) | 238 (68) | NSb |
Smoking status, number (percentage) | Â | Â |
   Never smoked | 157 (44.8) | NS |
   Ex-smoker | 133 (38) |  |
   Current smoker | 60 (17.2) |  |
Pack-years, median (quartiles) | 13.5 (5–30) | NSc |
BMI in kg/m2, mean ± SD | 27.1 ± 5.1 | NSa |
RA duration in years, median (quartiles) | 10 (4–19) | 0.01c |
Disease activity (DAS28), mean ± SD | 4.2 ± 1.37 | NSa |
CRP in mg/L, median (quartiles) | 16.8 (5–20.7) | NSc |
Hypertension, number (percentage) | 256 (73.1) | 0.008b |
Systolic BP in mm Hg, mean ± SD | 143.4 ± 20.9 | 0.002a |
Diastolic BP in mm Hg, mean ± SD | 78.9 ± 11.4 | NSa |
Total CHOL in mmol/L, mean ± SD | 5.2 ± 1.2 | 0.018a |
HDL CHOL in mmol/L, mean ± SD | 1.6 ± 0.45 | NSa |
TG in mmol/L, median (quartiles) | 1.43 (1–1.6) | 0.001c |
Diabetes mellitus, number (percentage) | 25 (7.1) | NSb |
HOMA IR, median (quartiles) | 1.95 (1.2–3.3) | 0.05c |
QUICKI, mean ± SD | 0.34 ± 0.04 | 0.05a |
DMARDs, number (percentage) | 303 (86.5) | NSb |
MTX, number (percentage) | 196 (56) | NSb |
MTX dose in mg, median (quartiles) | 10 (7.5–18.7) | NSc |
Prednisolone, number (percentage) | 110 (31.4) | NSb |
Prednisolone dose in mg, median (quartiles) | 7.5 (4.3–10) | NSc |
NSAIDs, number (percentage) | 68 (19.4) | NSb |
COX-II inhibitors, number (percentage) | 31 (8.8) | NSb |
ACE inhibitors, number (percentage) | 91 (26) | 0.001b |
Diuretics, number (percentage) | 87 (24.8) | 0.02b |
Aspirin, number (percentage) | 57 (16.2) | NSb |